TTK Healthcare

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE910C01018
NSEID: TTKHLTCARE
BSEID: 507747

INR

1,200.00

36.75 (3.16%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.98 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2024 is 11.36% vs 0.71% in Dec 2023

Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 29.79% vs 7.42% in Dec 2023

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is 44.01% vs -36.58% in Dec 2023

Interest

YoY Growth in quarter ended Dec 2024 is 256.52% vs -70.51% in Dec 2023

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023

Compare Quarterly Results Of TTK Healthcare With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

204.74

2,396.57

-2,191.83

-91.46%

Other Operating Income

0.00

Total Operating income

204.74

2,396.57

-2,191.83

-91.46%

Raw Material Cost

46.66

179.72

-133.06

-74.04%

Purchase of Finished goods

44.32

445.60

-401.28

-90.05%

(Increase) / Decrease In Stocks

7.05

34.08

-27.03

-79.31%

Employee Cost

38.43

521.79

-483.36

-92.63%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

60.59

474.45

-413.86

-87.23%

Total Expenditure (Excl Depreciation)

197.05

1,655.64

-1,458.59

-88.10%

Operating Profit (PBDIT) excl Other Income

7.69

740.93

-733.24

-98.96%

Other Income

17.84

69.82

-51.98

-74.45%

Operating Profit (PBDIT)

25.53

810.75

-785.22

-96.85%

Interest

0.82

199.47

-198.65

-99.59%

Exceptional Items

0.00

Gross Profit (PBDT)

24.71

611.28

-586.57

-95.96%

Depreciation

2.11

87.03

-84.92

-97.58%

Profit Before Tax

22.59

524.25

-501.66

-95.69%

Tax

5.86

107.87

-102.01

-94.57%

Provisions and contingencies

0.00

Profit After Tax

16.73

416.38

-399.65

-95.98%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

16.73

416.38

-399.65

-95.98%

Equity Capital

14.13

40.06

-25.93

-64.73%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

11.84

10.39

1.45

13.96%

Diluted Earnings per share

11.84

10.33

1.51

14.62%

Operating Profit Margin (Excl OI)

3.76%

30.92%

0.00

-27.16%

Gross Profit Margin

12.07%

25.51%

0.00

-13.44%

PAT Margin

8.17%

17.37%

0.00

-9.20%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 204.74 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 3.15% vs -4.53% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 11.36% vs 0.71% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 16.73 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -2.73% vs -45.54% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 29.79% vs 7.42% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 7.69 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -6.56% vs 19.28% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 44.01% vs -36.58% in Dec 2023

Quarterly - Interest

Interest 0.82 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 10.81% vs -13.95% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 256.52% vs -70.51% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 3.76%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023